A major new analysis has revealed, for the first time, a possible cause for most cases of acute lymphoblastic leukemia and has discovered that it is likely to be preventable.
Browsing: Disease Area > Hematologic
In this review article find out which treatment plan is most appropriate for different groups of acute lymphoblastic leukemia patients.
In this interview discover some of the challenges in developing CAR-T therapies for solid tumors as well as major milestones in their development and where the field is heading.
Researchers have discovered first leukemia protective gene that is specific to the male-only Y chromosome.
Green light from NICE for NSCLC immunotherapy; Pan-Cancer Atlas data and 40 myeloma genes unearthed.
In this joint interview we delve deeper into the news story to find out both the clinician’s and patient’s perspective on the recent recommendation of ixazomib for NHS distribution.
John Ellwood discusses the treatment he underwent following his diagnosis with myeloma.
A new drug, termed ixazomib, is to be used in combination with standard treatments and has been made available on the Cancer Drug Fund.
Researchers from the Dana-Farber Cancer Institute (MA, USA) have conducted the largest genomic analysis of patients with smoldering multiple myeloma –a precursor to multiple myeloma. The results may offer a new insight into the mechanism of multiple myeloma progression.
Results from a pair of clinical trials evaluating the CAR-T cell therapy Kymriah™ have demonstrated long-lasting remissions in non-Hodgkin’s lymphoma patients.